SARS-CoV-2 Spike (S) protein reactive T cells were identified in immunocompetent patients suffering from moderate, severe, and critical COVID-19 [15] and a dominance of CD4+ T-cell over CD8+ T-cell response was observed in severe COVID-19 patients [16]. The gene discussed is CD8A; the disease is COVID-19.